Newsfeed

Bipartisan Senate Team Wants To Move On Site Neutral Payments

Sens. Bill Cassidy, R-LA, and Maggie Hassan, D-NH, unveiled their support for a bill that would begin paying hospital outpatient facilities lower Medicare reimbursements much more consistent with what other places of service receive for the same services – known as “site-neutral” payments. The bill would equalize payments for common outpatient services at hospital-owned offsite locations, ambulatory surgery centers, and other clinics.

Check out my blog on site neutral payments here:  https://www.healthcarelabyrinth.com/it-is-time-for-site-neutral-payments-in-our-healthcare-system/ . We know that the lack of site neutral payments cost us huge sums and we need to reform this in Medicare. Commercial payments would then be transitioned as many commercial plans base rates on Medicare. The hospital lobby’s ridiculous arguments may finally be giving way to common sense. Kudos to Cassidy and Hassan. We need full site neutral payments as quickly as possible.

There is the possibility of inclusion in a lame deck session bill. Wisely, their bill would use some savings to support rural and other critical hospitals.

(Article may require a subscription.)

#siteneutral #hospitals #medicare

https://www.modernhealthcare.com/politics-policy/senators-look-expand-site-neutral-payment-policy

Read More »

Medicare Advantage Penetration Saves Medicare Dollars

A new study from Elevance Health says that growth in Medicare Advantage (MA) leads to lower overall Medicare spending. This in part counters the shouts of MA opponents who cry about overpayments in the program.

The study found that Medicare spending was $431 billion less from 2010 to 2020 than the Congressional Budget Office (CBO) predicted. The difference was per enrollee spending during the timeframe.

The lower spending trend due to MA growth is most noticeable in midwestern and southern counties, but weaker in northwest and western counties. Researchers found that a 10% percent higher MA penetration in a county points to a 1.9% decrease in Medicare spending, correlating to a $204 decrease in per person spending. This resulted in up to $144 billion cumulative savings from 2012 to 2021.

One theory is that higher penetration of MA introduces a change in provider behavior in both MA and FFS. There is a halo effect over the traditional fee-for-service (FFS) program as providers concentrate on outcomes and lower costs for all their patients.

Even with risk-adjustment payments factored in, $116 billion in savings remained. And the magnitude of such overpayments are certainly debatable.

Changes in some reimbursement and risk adjustment reform may be needed, but the study counters the gross exaggeration of MA opponents that somehow the MA program is simply a play for companies to make money with no concomitant benefits to enrollees or the program. This as well as key Better Medicare Alliance studies showing better outcomes should be the playbook to defend MA.

#medicareadvantage

https://www.fiercehealthcare.com/payers/higher-ma-enrollment-linked-lower-medicare-spending-report

Read More »

Speaker Johnson Says Obamacare Not In Jeopardy

With control of the U.S. House coming down to a small number of the 435 seats in the chamber, House Speaker Mike Johnson said today that Obamacare is not on the so-called hit list. While he acknowledged that healthcare reform is certainly on the agenda, he did admit that the Affordable Care Act (ACA) is part of the healthcare fabric. He disputed Democrats’ campaign assertions that he wants to repeal the law, saying: “The ACA is so deeply ingrained. We need massive reform to make this work, and we’ve got a lot of ideas on how to do that.”

While Johnson said this, on the campaign trail Donald Trump and running mate JD Vance seem to indicate that they have a plan to introduce high-risk pools and move the adverse out of regular insurance pools.  Vance later claimed he meant reinsurance would be introduced, leading me to think they really have no idea what alternative they really have as the two concepts are very different. The Harris campaign of course says the ACA is in jeopardy given Trump’s and the GOP’s past efforts to repeal the ACA.

#aca #obamacare #exchanges #speakerjohnson #harris #trump #election2024

https://thehill.com/homenews/house/4962432-johnson-republicans-obamacare-harris/?tbref=hp

Read More »

CMS Touts ACO Savings

Touting its efforts to reform the Medicare fee-for-service (FFS) program by using value-based payments and care, the Centers for Medicare and Medicaid Services (CMS) announced that the Medicare Shared Savings Program (MSSP) saved Medicare $2.1 billion in 2023, the largest yearly savings in the program’s history. The MSSP is also known as Accountable Care Organizations (ACOs).

While this may have been the largest net savings, the reality is that there is at best a mixed record on the value-based care programs in the traditional system. Some studies suggest that the administrative costs of all of the programs exceed any savings. And the savings over time have been largely small. ACOs are perhaps the most successful, though.

Additional articles: https://insidehealthpolicy.com/daily-news/cms-aco-stakeholders-tout-record-mssp-savings and https://www.cms.gov/newsroom/press-releases/medicare-shared-savings-program-continues-deliver-meaningful-savings-and-high-quality-health-care

(Some articles may require a subscription.)

#medicare #vbc #valuebasedcare

https://www.fiercehealthcare.com/payers/mssp-acos-saves-medicare-21-billion-2023-largest-savings-program-history

Read More »

Coverage Expansion Saves Overall Healthcare Costs

I absolutely loved this Health Affairs Forefront Blog arguing for an expansion of coverage and getting to true affordable universal access. It explicitly asks: “It is thus an ideal time to ask: Why aren’t we covering everyone and working to make care affordable for all?”

The authors dissect well opponents’ positions that the Affordable Care Act (ACA) drove up costs and that trimmed down benefit packages are just fine. They beat down both arguments with good statistics.

First, citing national healthcare expenditure data, they show that the ACA insurance expansions did not lead to accelerated cost growth. Second, they note that high-deductible health plans have negative impacts. Third, they argue that expansion might actually drive down cost growth more.

They conclude that “we can have universal coverage, affordable cost sharing, and continued cost growth deceleration.”

These points line up with my proposals for healthcare reform here: https://www.healthcarelabyrinth.com/a-modest-election-year-proposal-for-healthcare-reform/ and https://www.healthcarelabyrinth.com/digging-into-my-modest-election-year-proposal-for-healthcare-reform-part-1-the-importance-of-price-reform/ and https://www.healthcarelabyrinth.com/digging-into-my-modest-election-year-proposal-for-healthcare-reform-part-2-pivoting-to-care-management-from-our-obsession-with-utilization-management/ and https://www.healthcarelabyrinth.com/digging-into-my-modest-election-year-proposal-for-healthcare-reform-part-3-driving-to-affordable-universal-access/

I will likely reflect more on this in a new blog soon.

(Article may require a subscription.)

#healthcare #healthreform #healthinsurance #coverage #aca #medicaid #obamacare #exchanges

https://www.healthaffairs.org/content/forefront/aca-did-not-increase-spending-growth-so-we-can-expand-coverage-further

Read More »

OIG Says CMS Does Not Ensure Part D Denies Part A Drugs

A new audit report from the Department of Health and Human Services Office of Inspector General (HHS OIG) is calling on CMS to enact certain reforms to prevent Medicare Part D from making additional payments for drugs that are supposed to be covered under the Part A benefit. Certain drugs that might normally be under Part D are under Part A when someone is in hospice or in certain facilities. Medicare Advantage and Part D plans should proactively determine what part of Medicare should be charged.

This has been a long-standing issue in the Medicare program. The audit looked at more than 2.5 million prescription drug events (PDE) for 2018 through 2020. It looked at anomalies in a sample. Extrapolating the results, it says Part D improperly paid up to $465.1 million. About $245.4 million of that amount was for drugs that medical records show were administered to Part D enrollees during their Part A skilled nursing facility stays. Part D enrollees paid approximately $21 million in cost-sharing.

(Article may require a subscription.)

#medicareadvantage #partd #medicare

https://insidehealthpolicy.com/inside-drug-pricing-daily-news/oig-cms-stop-redundant-part-d-payments-covered-drugs

Read More »

HHS OIG Accuses MA Plans Of Inflating Risk Adjustment Submissions

In a follow-up to an earlier review, the Health and Human Services’ Office of Inspector General (HHS OIG) concluded that Medicare Advantage (MA) insurers could be using health risk assessments (HRAs) to inflate risk adjustment payments through upcoding. The OIG says an estimated $7.5 billion in risk-adjusted payments tied to HRAs was received by MA insurers but the diagnoses substantiating them did not appear on separate encounters.

Just 20 MA companies drove 80% of the questionable revenue. HHS OIG recommends a series of reforms. UnitedHealth Group received two-thirds of such risk-adjusted payments despite only managing 28% of MA enrollees. I have previously said MA plans should get ready for restrictions or elimination of HRAs and chart reviews in risk adjustment. However, the Centers for Medicare and Medicaid Services (CMS) did not concur with the HHS OIG findings, saying the study was not definitive.

I will have an in-depth blog on this next week and recap all studies on the subject out there.

In other MA news:

  • A good article summarizing the 2025 Star Year controversy and why three big plans are suing CMS.
  • An article summarizing market exits and benefit terminations, most of which are from Humana, Aetna, and United Healthcare.
  • An article on how plans are approaching the enrollment season given major cutbacks.

Additional article: https://www.modernhealthcare.com/policy/medicare-advantage-overpayments-cms-oig-2023 and https://www.beckerspayer.com/policy-updates/medicare-advantage-plans-made-7-5b-from-questionable-assessments-in-2023-oig.html and https://www.modernhealthcare.com/legal/humana-unitedhealthcare-medicare-advantage-star-ratings-lawsuit-cms-hhs and https://www.beckerspayer.com/payer/medicare-advantage-market-exits-causing-the-most-disruption.html and https://www.beckerspayer.com/leadership/how-medicare-advantage-plans-are-approaching-a-tumultuous-open-enrollment.html

(Some articles may require a subscription.)

#medicareadvantage #cms #riskadjustment #stars

https://www.fiercehealthcare.com/payers/medicare-advantage-plans-received-billions-medicare-home-visits-feds-are-skeptical

Read More »

Centene Next To Sue CMS Over Star Ratings

Centene has become the latest big Medicare Advantage (MA) plan to sue the Centers for Medicare and Medicaid Services (CMS) over its 2025 Star ratings. United and Humana have already done so.

As with the other two plans, Centene argues with CMS’ call center measures. Its complaint raises three fundamental issues. First, relying on a handful of secret shopper calls in a given measure is unreasonable. Second, the 5-Star score requires 100% of TTY calls to be successfully completed and inclusion of even a single incorrect TTY call in the denominator has significant negative impact. Third, CMS mishandled and scored one TTY call to Centene’s detriment.

Centene says the one call will cost the plan $73 million in revenue.

In other news, brokers and agents are very worried about the impact of major reductions in the MA and standalone Part D (PDP) plans. They say that demand for Medicare Supplement policies will surge. The good news is that most states allow Medicare supplement carriers to underwrite policyholders switching from MA without underwriting.

In addition, agents and brokers note that MA and PDP plans are limiting or eliminating commissions. WellCare will not pay for selling PDP plans, Aetna will not pay for new PDP members, and Humana and Cigna will not pay for new members in certain PDPs.

Additional articles: https://www.healthcaredive.com/news/centene-medicare-advantage-star-ratings-lawsuit-hhs/730696/ and https://www.beckerspayer.com/payer/one-phone-call-cost-centene-73-million-lawsuit-alleges.html and https://www.modernhealthcare.com/insurance/centene-medicare-advantage-star-ratings-lawsuit and https://www.modernhealthcare.com/insurance/insurance-brokers-banking-consumers-medicare-confusion

(Some articles may require a subscription.)

#medicareadvantage #agents #brokers #marketing #coverage #cms #stars

https://www.fiercehealthcare.com/payers/not-be-left-out-centene-sues-cms-over-2025-star-ratings

Read More »

Cigna-Humana Possible Merger Explained

With news that the Cigna-Humana merger could be back on, financial analysts are reviewing what it could mean for healthcare. The merger looks to be very complimentary, with very little overlap. A combined company would have a $121 billion market capitalization, still tiny compared with UnitedHealth Group’s $528 billion.

On the insurance side, Cigna is a major commercial provider with 16.1 million members. Humana had fewer than 600,000 commercial customers and is closing this line down.

Humana is the second-largest Medicare insurer with 8.8 million members (Medicare Advantage and standalone Part D PDP). It has about 1.2 million Medicaid lives. Cigna is selling its Medicare line to Health Care Service Corporation (HCSC, a big Midwest and South Blue). This began last year when the first talks were ongoing and continued after they broke down. Cigna CEO David Cordani felt too much would have to be invested to fix Cigna MA’s poor financial standing. Cigna has no Medicaid after selling its Texas plan some years ago.

Express Scripts is the third-largest PBM, while Humana’s is a minor player.

Thus, the move could attract less antitrust scrutiny than past deals. But analysts also say that the merger’s completion may hinge on the presidential election outcome. A Harris administration is likely to be activist on mergers of any kind.  A Trump administration would be laxer.

Additional article: https://www.bloomberg.com/news/articles/2024-10-21/cigna-humana-merger-plan-may-hinge-on-election-analysts-say

(Some articles may require a subscription.)

#mergers #consolidations #manda #antitrust #humana #cigna #medicareadvantage #medicaid #managedcare #employercoverage

https://www.modernhealthcare.com/mergers-acquisitions/cigna-humana-deal-antitrust-medicare-advantage

Read More »

Humana Sues CMS Over Star Scores

In the broadest lawsuit yet over Star scores, Humana has sued the Centers for Medicare and Medicaid Services (CMS) over its 2025 Star ratings. Lawsuits in 2024 from Scan and Elevance Health and in 2025 from United and Humana are relatively tame, arguing specific points of regulation or on a specific measure or measures. United has used the phrase “arbitrary and capricious” in detailing its lawsuit, but the Humana suit argues that in spades compared with United.

Humana argues that the entire Star program is administered in an arbitrary and capricious manner in violation of the administrative procedures act. The argument has much greater significance now due to the Supreme Court striking down the so-called Chevron deference precedent, which gave agencies fairly wide-ranging authority to set regulations and interpret ambiguities. Of note, the suit has been filed in the Northern District of Texas before Judge Reed O’Connor, who has a record of striking down agencies’ regulations.

Humana says CMS is not following its own regulations by not disclosing all Star ratings calculation criteria. Humana says CMS calculated two Star ratings measures incorrectly. United limited its suit to one customer service phone call that impacted its ratings. Humana’s lawsuit argues three phone calls were scored unfairly.

The Humana lawsuit is a gamble but not necessarily unreasonable. The argument is not wrong that CMS does not adequately disclose all the information plans need to calculate their own Stars to assess where they are. I would note the following, some of which are cited by Humana in its suit:

— Plans do not receive critical improvement measure information until Plan Preview 2 and have no time to assess it.

— The consumer assessment (CAHPS) and health outcome (HOS) surveys are fully anonymized and plans must trust CMS and its vendor to choose samples that meet enrollment criteria and then calculate all factors and scores correctly. The CAHPS case mix adjustment is a black box that few if any have been able to crack. CMS and vendors are protective of what they turn over to plans. In essence, MA plans are pretty blind on 12 measures (soon to be 14).

— There have been recent reports of inaccurate designation of Low Income Subsidy (LIS) individuals, which impacts the Categorical Adjustment Index (CAI) in Star and other critical Medicare Advantage (MA) operations.

— While certain Tukey information has been released, calculating cut points indeed has been a challenge. Humana says it could not replicate 60% of CMS’ cut point calculations after Star ratings were released. Humana says CMS was not disclosive when they asked the agency “to provide greater transparency into their policies, practices and calculations.” The Humana demand is entirely reasonable, especially in light of the fact that the agency was reprimanded by two federal court judges last year for blatantly ignoring regulations regarding guard rails that must be applied when setting cut points.

On the issue of call center measures, it seems evident that there is inconsistency in how CMS adjudicates TTY and foreign language services. The TTY and interpreter systems are prone to technological failure, not all the time the fault of the MA plan or its technology vendors. CMS’ secret shoppers do not always conduct the calls correctly and then penalize plans. Of all the measures, the call center measures are perhaps the most controversial and subject to interpretation. Elevance Health certainly proved the point last year. The high thresholds demanded and the sometimes punitive nature of CMS’ assessment practices are concerning.

Capitol Hill will look at the reasons behind falling Star scores as well as whether the government is getting its value from MA rebates from the Star program. I recently said that I support the concept of CMS running a continuous quality improvement program and have generally supported CMS on Stars. But Congress should also look at whether the Star program is being run fairly and transparently. Humana has made some very good points in its lawsuit.

In other news, CMS Chief Deputy Administrator Jon Blum fired a shot across MA plans’ bows today when he stated that MA plans must prove they deliver enough value for the extra federal reimbursement they receive. He specifically cited the funding disparity. He is alluding to MA overpayments as well as questions on supplemental benefit utilization. I expect 2026 regulations soon to be offered to promote certain reforms on the overpayment and other fronts, perhaps including Star. Of course, Blum and others continue to cite misleading statistics that MA is over-reimbursed by 22% to as much as 39%.

Additional articles: https://www.modernhealthcare.com/insurance/humana-medicare-advantage-star-ratings-lawsuit-cms and https://www.healthcaredive.com/news/humana-medicare-advantage-star-ratings-lawsuit-hhs/730387/ and https://insidehealthpolicy.com/daily-news/cms-official-calls-medicare-advantage-prove-value-amid-growing-concerns-over-payment-gap

(Some articles may require a subscription.)

#cms #medicareadvantage #stars

https://www.fiercehealthcare.com/payers/humana-joins-chorus-lawsuits-over-sinking-star-ratings

Read More »

Available Now

$30.00